Table 4.
Variable | Total participants* | Men# | Women# |
---|---|---|---|
OR (95% CI) | OR (95% CI) | OR (95% CI) | |
Non-obese, no risk | Reference | Reference | Reference |
Non-obese, hyperglycemia | 1.047 (1.035-1.059) | 0.996 (0.978-1.014) | 1.092 (1.075-1.108) |
Non-obese, hypertension | 1.284 (1.276-1.292) | 1.252 (1.241-1.264) | 1.303 (1.293-1.314) |
Non-obese, dyslipidemia | 1.521 (1.505-1.537) | 1.361 (1.337-1.385) | 1.635 (1.613-1.657) |
Obese, no risk | 1.014 (1.004-1.024) | 0.865 (0.848-0.883) | 1.092 (1.080-1.105) |
Obese, hyperglycemia | 1.144 (1.121-1.167) | 0.958 (0.920-0.998) | 1.241 (1.213-1.271) |
Obese, hypertension | 1.361 (1.348-1.375) | 1.190 (1.169-1.212) | 1.461 (1.444-1.478) |
Obese, dyslipidemia | 1.707 (1.670-1.746) | 1.360 (1.302-1.420) | 1.893 (1.844-1.944) |
*The model was adjusted for sex, age, race, smoking, alcohol consumption, chronic kidney disease, chronic respiratory disease, liver-related diseases, HIV infection, and coronary heart disease. #The model was adjusted for age, race, smoking, alcohol consumption, chronic kidney disease, chronic respiratory disease, liver-related diseases, HIV infection, and coronary heart disease.